Skip to main content
. 2023 May 9;19(1):2206278. doi: 10.1080/21645515.2023.2206278

Figure 2.

Figure 2.

Major concerns about receiving COVID-19 vaccination in patients with neuromuscular diseases.

The three commonest concerns from patients with neuromuscular diseases were having a higher chance of AEs compared to healthy individuals (22.0%), safety (22.0%), and suitability (14.3%). AEs = adverse effects.